Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Shares of Affymetrix jumped 19 percent Thursday after the Swiss drug firm Roche said it would pay $70 million for a license to use the Santa Clara company's DNA chips to create new ways to diagnose ...

Affymetrix, the Santa Clara-based DNA chip company, has partnered with Hewlett Packard in the development of the HP GeneArray Scanner, a high resolution, high throughput scanner for use with GeneChip¨ ...

An operator uses Affymetrix's Sigma Aligner machine for gene chip array manufacturing in Singapore. Affymetrix Inc. (Santa Clara, CA) has opened a manufacturing facility in Singapore for its GeneChip ...

LOS ANGELES, Jan 31 (Reuters) - Affymetrix Inc on Thursday said its fourth-quarter profit rose 47 percent on higher sales of its microchips used in genetic research and drug development. Affymetrix, ...

BANGALORE, Oct 22 (Reuters) - Shares of Affymetrix Inc sank 21 percent on Thursday, a day after it reported a wider-than-expected quarterly loss hurt by weak gross margins, and forecast fourth-quarter ...

Affymetrix Inc.’s spinoff Perlegen announced that it has filed with regulators to hold an initial public offering of its stock, making it one of the first personalized-medicine companies to go public.